XC221
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for XC221, covering 2018-03-08 to 2023-10-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections [Phase 3]